Compare CMT & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMT | IMRX |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | United States | United States |
| Employees | 1239 | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.1M | 232.3M |
| IPO Year | 1996 | 2021 |
| Metric | CMT | IMRX |
|---|---|---|
| Price | $22.54 | $3.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 33.0K | ★ 742.7K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 37.75 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $284,290,000.00 | N/A |
| Revenue This Year | $0.58 | N/A |
| Revenue Next Year | $8.99 | N/A |
| P/E Ratio | $49.24 | ★ N/A |
| Revenue Growth | ★ 5.49 | N/A |
| 52 Week Low | $17.36 | $3.35 |
| 52 Week High | $28.69 | $8.48 |
| Indicator | CMT | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 49.87 |
| Support Level | $18.22 | $3.38 |
| Resistance Level | $24.13 | $4.16 |
| Average True Range (ATR) | 0.96 | 0.25 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 52.33 | 56.52 |
Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.